Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement.
Across FY2008–FY2025: $7.66M in buybacks, $18.19B in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Issuer evidence: On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Supporting evidence: The Notes were issued under an Indenture, dated as of March 15, 2010 (the “Indenture”), as amended by Supplemental Indenture No. 23, dated as of April 1, 2022 (“Supplemental Indenture No. 23”), among the Company, the Guarantor and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), each of which was incorporated by reference into the Registration Statement, as supplemented by Supplemental Indenture No. 25, dated as of July 13, 2026 (“Supplemental Indenture No. 25”), among the Company, the Guarantor and the Trustee. The 2031 Notes bear interest at a rate of 3.850% per year, payable semiannually in arrears on February 15 and August 15 of each year, commencing February 15, 2027. The 2031 Notes will mature on August 15, 2031. The 2033 Notes bear interest at a rate of 4.150% per year, payable semiannually in arrears on February 15 and August 15 of each year, commencing February 15, 2027. The 2033 Notes will mature on August 15, 2033. The Company intends to use the net proceeds from the sale of the Notes for general corporate purposes, including repayment of debt and funding of our pipeline of investment opportunities in healthcare and seniors housing properties. Pending such use, the net proceeds may be invested in short-term, investment grade, interest-bearing securities, certificates of deposit or indirect or guaranteed obligations of the United States.
Supporting evidence: On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Supporting evidence: On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
4.150% Notes due 2033
Note · Welltower OP LLC
Reference: 4.150% Notes due 2033
Active
Original principal
CAD 400,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
Aug 15, 2033
Last reported interest terms:
4.15%
Reported 2026-07-13Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Issuer evidence: On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Supporting evidence: The Notes were issued under an Indenture, dated as of March 15, 2010 (the “Indenture”), as amended by Supplemental Indenture No. 23, dated as of April 1, 2022 (“Supplemental Indenture No. 23”), among the Company, the Guarantor and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), each of which was incorporated by reference into the Registration Statement, as supplemented by Supplemental Indenture No. 25, dated as of July 13, 2026 (“Supplemental Indenture No. 25”), among the Company, the Guarantor and the Trustee. The 2031 Notes bear interest at a rate of 3.850% per year, payable semiannually in arrears on February 15 and August 15 of each year, commencing February 15, 2027. The 2031 Notes will mature on August 15, 2031. The 2033 Notes bear interest at a rate of 4.150% per year, payable semiannually in arrears on February 15 and August 15 of each year, commencing February 15, 2027. The 2033 Notes will mature on August 15, 2033. The Company intends to use the net proceeds from the sale of the Notes for general corporate purposes, including repayment of debt and funding of our pipeline of investment opportunities in healthcare and seniors housing properties. Pending such use, the net proceeds may be invested in short-term, investment grade, interest-bearing securities, certificates of deposit or indirect or guaranteed obligations of the United States.
Supporting evidence: On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Supporting evidence: On July 13, 2026, Welltower OP LLC (the “Company”) issued C$750,000,000 aggregate principal amount of the Company’s 3.850% Notes due 2031 (the “2031 Notes”) and C$400,000,000 aggregate principal amount of the Company’s 4.150% Notes due 2033 (the “2033 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to an automatic shelf registration statement of the Company and the Guarantor (as defined below) on Form
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
13.13×
Peer median 8.77×
EV/EBIT
—
P/E (TTM)
97.95×
Peer median 38.40×
P/FFO (TTM)
63.33×
Peer median 22.58×
Peer medians compare against the 10 similar-size REIT - Healthcare Facilities companies (of 17 listed).
P/FFO uses
the company-stated
“NAREIT FFO attributable to common stockholders”,
extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
P/FFO uses
the company-stated
“NAREIT FFO attributable to common stockholders”,
extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
